Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

492.216
+1.1110.23%
Number of Gainers:27
Number of Losers:23
Number of Flat:1
PE:- -
High:494.856
Open:491.038
Low:485.429
Close:491.104
Volume:505.55M
Turnover:14.63B
Market Cap:3.11T
Float Cap:2.18T

Loading ...

3SBio (SEHK:1530) Stock Sees Margin Strength Clash With Profit Decline

Simply Wall St.
·
Aug 21

Blue Moon Group Holdings (SEHK:6993) Stock Can Improving Losses Revive Profitability

Simply Wall St.
·
Aug 21

Humanoid Robot Debut Drives Xiaomi's Rally; Alibaba Slips Post-Earnings - How Far Is Hong Kong Internet Sector From Its 'DeepSeek Moment'?

Deep News
·
Aug 21

Junshi Biosciences Raises 700 Million Yuan Through Tech Innovation Bond Issuance

Stock News
·
Aug 21

China's Henlius H1 Revenue Jumps on Drug Sales, License Income

Reuters
·
Aug 21

Jefferies Adjusts Fuyao Glass Industry Group's Price Target to HK$73.70 From HK$78.10, Keeps at Buy

MT Newswires Live
·
Aug 21

Antengene-B Turns Profitable in First Half with Net Income of RMB216 Million

Stock News
·
Aug 21

Simcere Pharmaceutical Grants 795,000 RSUs Under 2021 Share Award Scheme

Reuters
·
Aug 21

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

JXR Reports Interim Results with Return to Profitability

Stock News
·
Aug 21

Antengene FY26 H1 Returns to Profit at RMB 216.35 Million; Revenue More than Doubled to RMB 513.08 Million

Reuters
·
Aug 21

Antengene Corporation H1 Net Income Attributable RMB 216.3 Million

THOMSON REUTERS
·
Aug 21

China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand

Reuters
·
Aug 21

Jinxin Fertility FY26 H1 Swings to Profit of RMB 110.3 Million; Revenue Rises 6.6% to RMB 1.37 Billion

Reuters
·
Aug 21

Jinxin Fertility Group H1 Net Income Attributable RMB 107.4 Million

THOMSON REUTERS
·
Aug 21

Guizhou Unveils 13 Typical Cases of Consumer Rights Violations in Market Regulation Crackdown

Deep News
·
Aug 21

JD Health International Stock Rallies 1.6% in Hong Kong

Dow Jones
·
Aug 21

Hansoh Pharmaceutical Group Stock Sheds 1.8% in Hong Kong

Dow Jones
·
Aug 21

AH Share Premium Tracker | August 21 Market Close

Stock News
·
Aug 21

Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating

Stock News
·
Aug 21